EFFICACY OF VEDOLIZUMAB IN A NATIONWIDE COHORT OF ELDERLY INFLAMMATORY BOWEL DISEASE PATIENTS

被引：0
|
作者：
Weiss, Alexandra
Trivedi, Chinmay
Pernes, Tyler
Patel, Manthankumar
Khan, Nabeel H.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fr524
引用
收藏
页码：S346 / S346
页数：1
相关论文
共 50 条
  • [1] Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Khan, Nabeel
    Pernes, Tyler
    Weiss, Alexandra
    Trivedi, Chinmay
    Patel, Manthankumar
    Medvedeva, Elina
    Xie, Dawei
    Yang, Yu-Xiao
    [J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 (05) : 734 - 744
  • [2] Efficacy and Safety of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Navaneethan, Udayakumar
    Kommaraju, Kiran Kumar
    Edminster, Timothy
    Zhu, Xiang
    Wilson, Kenneth
    Glover, Sarah C.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S812 - S812
  • [3] Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Nabeel Khan
    Carlos Vallarino
    Trevor Lissoos
    Umar Darr
    Michelle Luo
    [J]. Drugs & Aging, 2017, 34 : 859 - 868
  • [4] Risk of Malignancy in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients
    Khan, Nabeel
    Vallarino, Carlos
    Lissoos, Trevor
    Darr, Umar
    Luo, Michelle
    [J]. DRUGS & AGING, 2017, 34 (11) : 859 - 868
  • [5] Vedolizumab Is Safe in Elderly Veteran Patients With Inflammatory Bowel Disease
    Leung, Kenneth
    Jackson, Christian S.
    Hammami, Muhammad Bader
    [J]. CROHNS & COLITIS 360, 2021, 3 (03)
  • [6] Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease
    Navaneethan, Udayakumar
    Edminister, Timothy
    Zhu, Xiang
    Kommaraju, Kiran
    Glover, Sarah
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (04) : E17 - E17
  • [7] Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Dahiya, Dushyant Singh
    Chandan, Saurabh
    Bapaye, Jay
    Mohan, Babu P.
    Ramai, Daryl
    Kassab, Lena L.
    Chandan, Ojasvini C.
    Dulai, Parambir S.
    Kochhar, Gursimran S.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (04) : 378 - 388
  • [8] Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study
    Bor, Renata
    Fabian, Anna
    Matuz, Maria
    Szepes, Zoltan
    Farkas, Klaudia
    Miheller, Pal
    Szamosi, Tamas
    Vincze, Aron
    Rutka, Mariann
    Szanto, Kata
    Balint, Anita
    Nagy, Ferenc
    Milassin, Agnes
    Toth, Tibor
    Zsigmond, Ferenc
    Bajor, Judit
    Mullner, Katalin
    Lakner, Lilla
    Papp, Maria
    Salamon, Agnes
    Horvath, Gabor
    Sarang, Krisztina
    Schafer, Eszter
    Sarlos, Patricia
    Palatka, Karoly
    Molnar, Tamas
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 205 - 213
  • [9] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [10] Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study
    Cohen, Nathaniel Aviv
    Plevris, Nikolas
    Kopylov, Uri
    Grinman, Anna
    Ungar, Bella
    Yanai, Henit
    Leibovitzh, Haim
    Isakov, Naomi Fliss
    Hirsch, Ayal
    Ritter, Einat
    Ron, Yulia
    Shitrit, Ariella Bar-Gil
    Goldin, Eran
    Dotan, Iris
    Ben Horin, Shomron
    Lees, Charlie W.
    Maharshak, Nitsan
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (09) : 1076 - 1085
12345